MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol
The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
BCL2 family members are subject to regulation at multiple levels, providing checks on their ability to contribute to tumorigenesis. However, findings on post-translational BCL2 phosphorylation in different systems have been difficult to integrate. Another antiapoptotic family member, MCL1, exhibits a difference in electrophoretic mobility upon phosphorylation induced by an activator of PKC (12-O-tetradecanoylphorbol 13-acetate; TPA) versus agents that act on microtubules or protein phosphatases 1/2A. A multiple pathway model is now presented, which demonstrates that MCL1 can undergo distinct phosphorylation events - mediated through separate signaling processes and involving different target sites - in cells that remain viable in the presence of TPA versus cells destined to die upon exposure to taxol or okadaic acid. Specifically, TPA induces phosphorylation at a conserved extracellular signal-regulated kinase (ERK) site in the PEST region (Thr 163) and slows turnover of the normally rapidly degraded MCL1 protein; however, okadaic acid and taxol induce ERK-independent MCL1 phosphorylation at additional discrete sites. These findings add a new dimension to our understanding of the complex regulation of antiapoptotic BCL2 family members by demonstrating that, in addition to transcriptional and post-transcriptional regulation, MCL1 is subject to multiple, separate, post-translational phosphorylation events, produced in living versus dying cells at ERK-inducible versus ERK-indepe…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MCL-1 phosphorylation at T163 decreased acutely upon trametinib treatment consistent with a loss of ERK phosphorylation59 and then rebounded at later time points coinciding with activation of JNK (Fig. S11A).”
From LKB1 regulates JNK-dependent stress signaling and apoptotic dependency of KRAS-mutant lung cancers (2025) · cites this paper as [59]
In the citing paper
“ERK1/2 stabilise MCL1 through phosphorylation of T163 and indirectly through RSK-mediated inhibition of GSK39.”
From Targeting melanoma’s MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors (2019) · cites this paper as [9]
In the citing paper
“ERK-mediated phosphorylation of the MCL-1-PEST domain has been reported to limit MCL-1 degradation.”
From BCL-XL inhibition induces an FGFR4-mediated rescue response in colorectal cancer (2022) · cites this paper as Domina et al., 2004
In the citing paper
“Our data therefore suggest that the induction of MCL-1 protein upon A-1155463 treatment could be mediated by FGFR4-driven ERK signaling (Domina et al., 2004) (Figure 5C).”
From BCL-XL inhibition induces an FGFR4-mediated rescue response in colorectal cancer (2022) · cites this paper as Domina et al., 2004
Citations
Cites
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
Sears, R., Nuckolls, F., Haura, E., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,393 · cited 2×
“Since the degradation of a variety of other PEST proteins is affected by phosphorylation (Rechsteiner, 1990; Clurman et al., 1996; Chen et al., 2000; Gregory and Hann, 2000; Sears et al., 2000; Koepp et al., 2001), we wondered whether this might likewise be the case with MCL1.”
BackgroundCurrent Protocols in Protein Science
(2018) · Current Protocols in Protein Science · doi:10.1002/(issn)1934-3663 · Cited by 1,189
Ca 2+ -Induced Apoptosis Through Calcineurin Dephosphorylation of BAD
Wang, H.-G., Pathan, N., Ethell, I. M., Krajewski, S., Yamaguchi, Y., Shibasaki, F., McKeon, F., Bobo, T., Franke, T. F., & Reed, J. C. (1999) · Science · doi:10.1126/science.284.5412.339 · Cited by 1,132 · cited 2×
“This latter modification has been extensively characterized in the case of the proapoptotic family member BAD (Scheid et al., 1999; Wang et al., 1999; Harada et al., 2001).”
BackgroundTsujimoto, Y., & Croce, C. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.14.5214 · Cited by 1,106 · cited 1×
“Expression of such viability-regulating gene products is often aberrant in cancer, as exemplified by the BCL2 overexpression seen in follicular lymphoma (Tsujimoto and Croce, 1986).”
BackgroundYamamoto, K., Ichijo, H., & Korsmeyer, S. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8469 · Cited by 1,003 · cited 4×
“Conversion of Ser 70 and/or Ser 87 to Ala similarly resulted in enhanced viability promotion in human Jurkat or mouse WEHI231 cells (Yamamoto et al., 1999).”
BackgroundMethodInfluentialMCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2.
Kozopas, K. M., Yang, T., Buchan, H. L., Zhou, P., & Craig, R. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3516 · Cited by 961 · cited 3×
“…and slows turnover of the MCL1 protein We focused first on further studies with TPA, since we have extensively examined the effects of this agent on MCL1 expression and phosphorylation (Kozopas et al., 1993; Yang et al., 1996; Zhou et al., 1997; Townsend et al., 1998, 1999; Domina et al., 2000).”
BackgroundSelf-citationGeneration of Destabilized Green Fluorescent Protein as a Transcription Reporter
Li, X., Zhao, X., Fang, Y., Jiang, X., Duong, T., Fan, C., Huang, C.-C., & Kain, S. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.34970 · Cited by 846 · cited 2×
“MCL1 turnover was assessed using standard methods (Li et al., 1998; Akgul et al., 2000; Gregory and Hann, 2000; Cuconati et al., 2003), by exposing cells to cycloheximide to inhibit protein synthesis (25 mg/ml) and monitoring loss of the existing MCL1 protein over time by Western blotting.”
MethodDevelopment and maintenance of B and T lymphocytes requires antiapoptotic MCL-1
Opferman, J. T., Letai, A., Beard, C., Sorcinelli, M. D., Ong, C. C., & Korsmeyer, S. J. (2003) · Nature · doi:10.1038/nature02067 · Cited by 801 · cited 1×
“A distinctive characteristic of MCL1 in these systems, as in differentiating cells like ML-1 cells, is its ability to act in a rapid but often shortterm fashion, under conditions of changing cell phenotype (Craig, 2002; Opferman et al., 2003).”
BackgroundPhosphorylation-Dependent Ubiquitination of Cyclin E by the SCF Fbw7 Ubiquitin Ligase
Koepp, D. M., Schaefer, L. K., Ye, X., Keyomarsi, K., Chu, C., Harper, J. W., & Elledge, S. J. (2001) · Science · doi:10.1126/science.1065203 · Cited by 762 · cited 1×
“Since the degradation of a variety of other PEST proteins is affected by phosphorylation (Rechsteiner, 1990; Clurman et al., 1996; Chen et al., 2000; Gregory and Hann, 2000; Sears et al., 2000; Koepp et al., 2001), we wondered whether this might likewise be the case with MCL1.”
BackgroundElimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation
Nijhawan, D., Fang, M., Traer, E., Zhong, Q., Gao, W., Du, F., & Wang, X. (2003) · Genes & Development · doi:10.1101/gad.1093903 · Cited by 591 · cited 1×
“Whatever the mechanism, the importance of MCL1 turnover in the control of cell viability has recently been brought to the fore by the demonstration that loss of MCL1 is an early step in apoptosis induced by DNA damage or by the viral E1A protein (Cuconati et al., 2003; Nijhawan et al., 2003).”
Backgroundp70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD
Harada, H., Andersen, J. S., Mann, M., Terada, N., & Korsmeyer, S. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171301998 · Cited by 549 · cited 2×
“This latter modification has been extensively characterized in the case of the proapoptotic family member BAD (Scheid et al., 1999; Wang et al., 1999; Harada et al., 2001).”
BackgroundBcl-2 Phosphorylation Required for Anti-apoptosis Function
Ito, T., Deng, X., Carr, B., & May, W. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.11671 · Cited by 541 · cited 5×
“This is the case both with agents that stimulate cell growth/viability and PKC as well as with some of the above cytotoxic agents (Ito et al., 1997; Haldar et al., 1998; Srivastava et al., 1999; Yamamoto et al., 1999; Breitschopf et al., 2000).”
BackgroundInfluentialPhosphorylation of Bcl2 and regulation of apoptosis
Ruvolo, P., Deng, X., & May, W. (2001) · Leukemia · doi:10.1038/sj.leu.2402090 · Cited by 504 · cited 2×
“Similar studies on antiapoptotic BCL2 in several systems have yielded divergent results in terms of the role of this modification, and in terms of the conditions, sites, and kinases involved (reviewed in Blagosklonny, 2001; Ruvolo et al., 2001).”
BackgroundResultClurman, B. E., Sheaff, R. J., Thress, K., Groudine, M., & Roberts, J. M. (1996) · Genes & Development · doi:10.1101/gad.10.16.1979 · Cited by 488 · cited 1×
“Since the degradation of a variety of other PEST proteins is affected by phosphorylation (Rechsteiner, 1990; Clurman et al., 1996; Chen et al., 2000; Gregory and Hann, 2000; Sears et al., 2000; Koepp et al., 2001), we wondered whether this might likewise be the case with MCL1.”
BackgroundLuciano, F., Jacquel, A., Colosetti, P., Herrant, M., Cagnol, S., Pages, G., & Auberger, P. (2003) · Oncogene · doi:10.1038/sj.onc.1206792 · Cited by 477 · cited 1×
“…BCL2 family members undergo posttranslational phosphorylation, a modification that is of particular interest as it could provide an avenue for directly targeting these proteins (Ito et al., 1997; Scheid et al., 1999; Wang et al., 1999; Blagosklonny, 2001; Harada et al., 2001; Luciano et al., 2003).”
BackgroundPhosphorylation by Glycogen Synthase Kinase-3 Controls c-Myc Proteolysis and Subnuclear Localization
Gregory, M. A., Qi, Y., & Hann, S. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310722200 · Cited by 475 · cited 1×
“…protein (Townsend et al., 1999; Domina et al., 2000) is reminiscent of observations with cMYC, which is likewise subject to transcriptional upregulation and post-translational phosphorylation and stabilization (Sears et al., 1999; Gregory and Hann, 2000; Sears et al., 2000; Gregory et al., 2003).”
BackgroundSelf-citationGregory, M. A., & Hann, S. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2423-2435.2000 · Cited by 469 · cited 4×
“Since the degradation of a variety of other PEST proteins is affected by phosphorylation (Rechsteiner, 1990; Clurman et al., 1996; Chen et al., 2000; Gregory and Hann, 2000; Sears et al., 2000; Koepp et al., 2001), we wondered whether this might likewise be the case with MCL1.”
BackgroundMethodSelf-citationCurrent protocols in protein science
Howland, J. L. (1996) · Biochemical Education · doi:10.1016/s0307-4412(96)80025-2 · Cited by 462
Reduced Ubiquitin-Dependent Degradation of c-Jun After Phosphorylation by MAP Kinases
Musti, A. M., Treier, M., & Bohmann, D. (1997) · Science · doi:10.1126/science.275.5298.400 · Cited by 462 · cited 1×
“Overall, MCL1 may be regulated at multiple levels and in conjunction with other rapidly inducible genes such as cMYC, cFOS, and cJUN (Okazaki and Sagata, 1995; Musti et al., 1997).”
BackgroundRas Enhances Myc Protein Stability
Sears, R., Leone, G., DeGregori, J., & Nevins, J. R. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80308-1 · Cited by 460 · cited 1×
“…protein (Townsend et al., 1999; Domina et al., 2000) is reminiscent of observations with cMYC, which is likewise subject to transcriptional upregulation and post-translational phosphorylation and stabilization (Sears et al., 1999; Gregory and Hann, 2000; Sears et al., 2000; Gregory et al., 2003).”
BackgroundMaundrell, K., Antonsson, B., Magnenat, E., Camps, M., Muda, M., Chabert, C., Gillieron, C., Boschert, U., Vial-Knecht, E., Martinou, J.-C., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25238 · Cited by 399 · cited 1×
“…stress-activated protein kinases, which are of interest because these are among the various candidate MCL1/ BCL2 kinases (Blagosklonny et al., 1997; Maundrell et al., 1997; Scatena et al., 1998; Srivastava et al., 1998; Basu et al., 2000; Fan et al., 2000; Furukawa et al., 2000; Thomas et al.,…”
BackgroundRegulation of Bad Phosphorylation and Association with Bcl-xL by the MAPK/Erk Kinase
Scheid, M. P., Schubert, K. M., & Duronio, V. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.31108 · Cited by 384 · cited 3×
“This latter modification has been extensively characterized in the case of the proapoptotic family member BAD (Scheid et al., 1999; Wang et al., 1999; Harada et al., 2001).”
BackgroundSrivastava, R. K., Srivastava, A. R., Korsmeyer, S. J., Nesterova, M., Cho-Chung, Y. S., & Longo, D. L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.6.3509 · Cited by 365 · cited 1×
“…interest because these are among the various candidate MCL1/ BCL2 kinases (Blagosklonny et al., 1997; Maundrell et al., 1997; Scatena et al., 1998; Srivastava et al., 1998; Basu et al., 2000; Fan et al., 2000; Furukawa et al., 2000; Thomas et al., 2000; Deng et al., 2001; Inoshita et al., 2002;…”
BackgroundDeletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis
Srivastava, R. K., Mi, Q.-S., Hardwick, J. M., & Longo, D. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3775 · Cited by 336 · cited 3×
“However, the same mutation was observed to result in the opposite effect in human MDA-MB231 breast cancer cells exposed to taxol (Srivastava et al., 1999).”
BackgroundZhou, P., Qian, L., Kozopas, K. M., & Craig, R. W. (1997) · Blood · doi:10.1182/blood.v89.2.630 · Cited by 326 · cited 15×
“This represents an okadaic acidinduced increase of 2.2, 2.1, 1.5, and 7.5 for WT-MCL1, and Phosphomutants 1–3, respectively Oncogene et al., 2000), lending additional weight to the difference seen with the drug in the case of Phosphomutant 3.”
BackgroundMethodSelf-citationBreitschopf, K., Haendeler, J., Malchow, P., Zeiher, A. M., & Dimmeler, S. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1886-1896.2000 · Cited by 321 · cited 4×
“This agreed with an earlier observation, which was that TNFinduced dephosphorylation at Ser 87 resulted in accelerated ubiquitination and degradation of BCL2 (Dimmeler et al., 1999; Breitschopf et al., 2000).”
BackgroundResultInfluentialDNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells
Cuconati, A., Mukherjee, C., Perez, D., & White, E. (2003) · Genes & Development · doi:10.1101/gad.1156903 · Cited by 315 · cited 3×
“MCL1 turnover was assessed using standard methods (Li et al., 1998; Akgul et al., 2000; Gregory and Hann, 2000; Cuconati et al., 2003), by exposing cells to cycloheximide to inhibit protein synthesis (25 mg/ml) and monitoring loss of the existing MCL1 protein over time by Western blotting.”
BackgroundMethodDimmeler, S., Breitschopf, K., Haendeler, J., & Zeiher, A. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1815 · Cited by 314 · cited 2×
“This agreed with an earlier observation, which was that TNFinduced dephosphorylation at Ser 87 resulted in accelerated ubiquitination and degradation of BCL2 (Dimmeler et al., 1999; Breitschopf et al., 2000).”
BackgroundResultYang, T., Kozopas, K. M., & Craig, R. W. (1995) · The Journal of cell biology · doi:10.1083/jcb.128.6.1173 · Cited by 299 · cited 3×
“The membrane was subjected to autoradiography and to Western blotting using a polyclonal antibody prepared to bacterially produced MCL1 (the immunogen contained the entire 350 amino-acid residues of the human MCL1 protein; Yang et al., 1995).”
BackgroundMethodSelf-citationNovel Role for JNK as a Stress-activated Bcl2 Kinase
Deng, X., Xiao, L., Lang, W., Gao, F., Ruvolo, P., & May, W. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100279200 · Cited by 295 · cited 1×
“…among the various candidate MCL1/ BCL2 kinases (Blagosklonny et al., 1997; Maundrell et al., 1997; Scatena et al., 1998; Srivastava et al., 1998; Basu et al., 2000; Fan et al., 2000; Furukawa et al., 2000; Thomas et al., 2000; Deng et al., 2001; Inoshita et al., 2002; but see also Du et al., 2004).”
BackgroundFan, M., Goodwin, M., Vu, T., Brantley-Finley, C., Gaarde, W. A., & Chambers, T. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003776200 · Cited by 289 · cited 1×
“…among the various candidate MCL1/ BCL2 kinases (Blagosklonny et al., 1997; Maundrell et al., 1997; Scatena et al., 1998; Srivastava et al., 1998; Basu et al., 2000; Fan et al., 2000; Furukawa et al., 2000; Thomas et al., 2000; Deng et al., 2001; Inoshita et al., 2002; but see also Du et al., 2004).”
BackgroundCraig, R. (2002) · Leukemia · doi:10.1038/sj.leu.2402416 · Cited by 266 · cited 6×
“Increased MCL1 mRNA expression in differentiating myeloid cells has been suggested to be important for the maintenance of viability during commitment to differentiation (Craig, 2002).”
BackgroundInfluentialSelf-citationSurvival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases
Deng, X., Ruvolo, P., Carr, B., & May, W. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1578 · Cited by 247 · cited 2×
“H7 (May et al., 1994; Ito et al., 1997; Deng et al., 2000).”
MethodPhosphorylation and Inactivation of Myeloid Cell Leukemia 1 by JNK in Response to Oxidative Stress
Inoshita, S., Takeda, K., Hatai, T., Terada, Y., Sano, M., Hata, J., Umezawa, A., & Ichijo, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207951200 · Cited by 233 · cited 3×
“…among the various candidate MCL1/ BCL2 kinases (Blagosklonny et al., 1997; Maundrell et al., 1997; Scatena et al., 1998; Srivastava et al., 1998; Basu et al., 2000; Fan et al., 2000; Furukawa et al., 2000; Thomas et al., 2000; Deng et al., 2001; Inoshita et al., 2002; but see also Du et al., 2004).”
BackgroundResultScatena, C. D., Stewart, Z. A., Mays, D., Tang, L. J., Keefer, C. J., Leach, S. D., & Pietenpol, J. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30777 · Cited by 229 · cited 1×
“…kinases, which are of interest because these are among the various candidate MCL1/ BCL2 kinases (Blagosklonny et al., 1997; Maundrell et al., 1997; Scatena et al., 1998; Srivastava et al., 1998; Basu et al., 2000; Fan et al., 2000; Furukawa et al., 2000; Thomas et al., 2000; Deng et al., 2001;…”
BackgroundLutterbach, B., & Hann, S. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5510 · Cited by 220 · cited 1×
“2D-phosphopeptide mapping Radiolabeling with 32P-orthophosphoric acid, immunoprecipitation of MCL1, gel electrophoresis and transfer to membrane were carried out as described above, except that protran nitrocellulose (Schleicher and Schuell, Keene, NH, USA) was used (Lutterbach and Hann, 1994).”
MethodSelf-citationMay, W. S., Tyler, P. G., Ito, T., Armstrong, D. K., Qatsha, K. A., & Davidson, N. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47099-8 · Cited by 219 · cited 1×
“H7 (May et al., 1994; Ito et al., 1997; Deng et al., 2000).”
Okazaki, K., & Sagata, N. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00187.x · Cited by 211 · cited 1×
“Overall, MCL1 may be regulated at multiple levels and in conjunction with other rapidly inducible genes such as cMYC, cFOS, and cJUN (Okazaki and Sagata, 1995; Musti et al., 1997).”
BackgroundBingle, C. D., Craig, R. W., Swales, B. M., Singleton, V., Zhou, P., & Whyte, M. K. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909572199 · Cited by 191 · cited 1×
“It is also regulated post-transcriptionally through alternative splicing (Bingle et al., 2000).”
BackgroundSelf-citationZhou, P., Levy, N. B., Xie, H., Qian, L., Lee, C.-Y. G., Gascoyne, R. D., & Craig, R. W. (2001) · Blood · doi:10.1182/blood.v97.12.3902 · Cited by 186 · cited 3×
“After treatment with these various drugs, MCL1 was immunoprecipitated with a previously produced anti-MCL1 monoclonal antibody (Ab #31) (Zhou et al., 2001); this antibody was produced using Oncogene bacterially derived MCL1 protein as immunogen, where the protein was made using an expression vector…”
BackgroundMethodSelf-citationDeng, X., Gao, F., Flagg, T., & May, W. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2533920100 · Cited by 161 · cited 4×
“Alterations that affect the half-life of BCL2 also affect its antiapoptotic and antiproliferative activity (Deng et al., 2004).”
BackgroundResultInfluentialYang, T., Buchan, H. L., Townsend, K. J., & Craig, R. W. (1996) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199603)166:3<523::aid-jcp7>3.0.co;2-r · Cited by 160 · cited 6×
“As with TPA, there may be a connection between the fact that microtubule-directed agents stimulate MCL1 mRNA expression as well as MCL1 protein phosphorylation (Yang et al., 1996; Townsend et al., 1998).”
BackgroundSelf-citationZhou, P., Qian, L., Bieszczad, C. K., Noelle, R., Binder, M., Levy, N. B., & Craig, R. W. (1998) · Blood · doi:10.1182/blood.v92.9.3226 · Cited by 156
Self-citationDu, L., Lyle, C. S., Obey, T. B., Gaarde, W. A., Muir, J. A., Bennett, B. L., & Chambers, T. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m304935200 · Cited by 143 · cited 1×
“…among the various candidate MCL1/ BCL2 kinases (Blagosklonny et al., 1997; Maundrell et al., 1997; Scatena et al., 1998; Srivastava et al., 1998; Basu et al., 2000; Fan et al., 2000; Furukawa et al., 2000; Thomas et al., 2000; Deng et al., 2001; Inoshita et al., 2002; but see also Du et al., 2004).”
BackgroundUnwinding the loop of Bcl-2 phosphorylation
Blagosklonny, M. V. (2001) · Leukemia · doi:10.1038/sj.leu.2402134 · Cited by 129
Furukawa, Y., Iwase, S., Kikuchi, J., Terui, Y., Nakamura, M., Yamada, H., Kano, Y., & Matsuda, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m906893199 · Cited by 126 · cited 1×
“…among the various candidate MCL1/ BCL2 kinases (Blagosklonny et al., 1997; Maundrell et al., 1997; Scatena et al., 1998; Srivastava et al., 1998; Basu et al., 2000; Fan et al., 2000; Furukawa et al., 2000; Thomas et al., 2000; Deng et al., 2001; Inoshita et al., 2002; but see also Du et al., 2004).”
BackgroundTownsend, K. J., Zhou, P., Qian, L., Bieszczad, C. K., Lowrey, C. H., Yen, A., & Craig, R. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1801 · Cited by 123 · cited 4×
“…and slows turnover of the MCL1 protein We focused first on further studies with TPA, since we have extensively examined the effects of this agent on MCL1 expression and phosphorylation (Kozopas et al., 1993; Yang et al., 1996; Zhou et al., 1997; Townsend et al., 1998, 1999; Domina et al., 2000).”
BackgroundSelf-citationReynolds, J. E., Li, J., Craig, R. W., & Eastman, A. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0194 · Cited by 123 · cited 3×
“The Chinese Hamster Ovary (CHO) cell line is in use by others for a similar Oncogene purpose, and we had previously successfully transfected these cells with MCL1 (Reynolds et al., 1994, 1996).”
BackgroundSelf-citationVantieghem, A., Xu, Y., Assefa, Z., Piette, J., Vandenheede, J. R., Merlevede, W., de Witte, P. A. M., & Agostinis, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204348200 · Cited by 119 · cited 1×
“On the other hand, microtubule-damaging chemotherapeutic agents, such as taxol, stimulate BCL2 phosphorylation in breast, prostate, and other cancer cells (Basu and Haldar, 1998; Vantieghem et al., 2002).”
Backgroundp53 mediates Bcl-2 phosphorylation and apoptosis via activation of the Cdc42/JNK1 pathway
Thomas, A. E., Giesler, T. L., & White, E. (2000) · Oncogene · doi:10.1038/sj.onc.1203895 · Cited by 112 · cited 1×
“…among the various candidate MCL1/ BCL2 kinases (Blagosklonny et al., 1997; Maundrell et al., 1997; Scatena et al., 1998; Srivastava et al., 1998; Basu et al., 2000; Fan et al., 2000; Furukawa et al., 2000; Thomas et al., 2000; Deng et al., 2001; Inoshita et al., 2002; but see also Du et al., 2004).”
BackgroundSteinmann, K. E., Belinsky, G. S., Lee, D., & Schlegel, R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6843 · Cited by 102 · cited 1×
“The taxolinduced phosphorylation/band shift is closely linked to accumulation in G2/M phase and, while okadaic acid does not cause arrest in a cell cycle specific manner (Domina et al., 2000), it is known to produce certain mitotic events (Steinmann et al., 1991).”
BackgroundAkgul, C., Moulding, D. A., White, M. R. H., & Edwards, S. W. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01809-3 · Cited by 98 · cited 2×
“…phosphorylation in BL41-3 cells is associated with a slowing of turnover; the half-life increasing from B2 to B4 h. MCL1 turnover remains rapid after deletion of the PEST region (which is extensive), although some change is suggested by the observations at early time points (Akgul et al., 2000).”
BackgroundMethodTownsend, K. J., Trusty, J. L., Traupman, M. A., Eastman, A. R., & Craig, R. W. (1998) · Oncogene · doi:10.1038/sj.onc.1202035 · Cited by 96 · cited 5×
“As with TPA, there may be a connection between the fact that microtubule-directed agents stimulate MCL1 mRNA expression as well as MCL1 protein phosphorylation (Yang et al., 1996; Townsend et al., 1998).”
BackgroundMethodSelf-citationDomina, A. M., Smith, J. H., & Craig, R. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000915200 · Cited by 81 · cited 36×
“This is followed by a progressive increase in the shifted band, which occurs in concert with the accumulation in G2/M phase, the majority of the protein being observed as shifted only after 12–24 h (Figure 6a lower panel and Domina et al., 2000).”
BackgroundMethodResultSelf-citationFrom a choleretic to an immunomodulator: Historical review of ursodeoxycholic acid as a medicament
Makino, I., & Tanaka, H. (1998) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1998.tb00707.x · Cited by 67
Cloning and Characterization of a Novel Nuclear Bcl-2 Family Protein, zfMcl-1a, in Zebrafish Embryo
Chen, M., Gong, H., Cheng, C., Wang, J.-P., Hong, J., & Wu, J. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3977 · Cited by 28 · cited 1×
“Since the degradation of a variety of other PEST proteins is affected by phosphorylation (Rechsteiner, 1990; Clurman et al., 1996; Chen et al., 2000; Gregory and Hann, 2000; Sears et al., 2000; Koepp et al., 2001), we wondered whether this might likewise be the case with MCL1.”
BackgroundMatsuoka, K., Kiyokawa, N., Taguchi, T., Matsui, J., Suzuki, T., Mimori, K., Nakajima, H., Takenouchi, H., Weiran, T., Katagiri, Y. U., et al. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03033.x · Cited by 13 · cited 1×
“The amount of ERK2 used here is below that used by others for in vitro phosphorylation (Deng et al., 2000; Matsuoka et al., 2002).”
Method(2000) · Educational Psychology in Practice · doi:10.1080/713666108 · Cited by 1
Enzymatic Digestion of Proteins in Solution
Riviere, L. R., & Tempst, P. (1995) · Current Protocols in Protein Science · doi:10.1002/0471140864.ps1101s00
Cited by
The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions
Yoon, S., & Seger, R. (2006) · Growth Factors · doi:10.1080/02699050500284218 · Cited by 1,273
ERK signalling: A master regulator of cell behaviour, life and fate
Lavoie, H., Gagnon, J., & Therrien, M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0255-7 · Cited by 1,185
Maurer, U., Charvet, C., Wagman, A. S., Dejardin, E., & Green, D. R. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.02.009 · Cited by 881
“Interestingly, MCL-1 similarly shows increased stability when phosphorylated on threonine 163, which represents the GSK-3 priming phosphorylation in this protein (Domina et al., 2004).”
BackgroundSensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
Wertz, I. E., Kusam, S., Lam, C., Okamoto, T., Sandoval, W., Anderson, D. J., Helgason, E., Ernst, J. A., Eby, M., Liu, J., et al. (2011) · Nature · doi:10.1038/nature09779 · Cited by 794
ERK1/2 MAP kinases in cell survival and apoptosis
Lu, Z., & Xu, S. (2006) · IUBMB Life · doi:10.1080/15216540600957438 · Cited by 648
“Mcl-1, an anti-apoptotic member of the Bcl-2 family, is phosphorylated at Thr163 by ERK1/2, thus increasing its stability and enhancing its anti-apoptotic activity ( 67 ).”
Background
Metadata
- Authors
- Domina, A. M., Vrana, J. A., Gregory, M. A., Hann, S. R., & Craig, R. W.
- Affiliations
- Dartmouth College (US)
- Vanderbilt University (US)
- Corresponding author
- Craig, Ruth W
- Venue
- Oncogene
- Published
- 2004-06-07
- Volume
- 23
- Issue
- 31
- Pages
- 5301-5315
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2041230280
- Cited by
- 327
- References
- 58
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 6 · 2023: 15 · 2022: 13 · 2021: 24 · 2020: 10 · 2019: 16 · 2018: 9 · 2017: 15 · 2016: 14 · 2015: 16 · 2014: 29 · 2013: 26 · 2012: 25
- FWCI
- 3.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Hitchcock Foundation
- National Cancer Institute (R01-CA57359, R01CA057359)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- Mcl-1, protein phosphorylation, ERK signaling, protein stabilization, Bcl-2 family proteins, anti-apoptotic proteins, okadaic acid, paclitaxel, microtubule stabilization, protein phosphatase 2A, phorbol myristate acetate, post-translational regulation, apoptosis
- MeSH terms
- Amino Acid Sequence, Animals, Antineoplastic Agents, Phytogenic, Binding Sites, Carcinogens, Cell Survival, Dogs, Dose-Response Relationship, Drug, Enzyme Activation, Enzyme Inhibitors, Cricetinae, Humans, Molecular Sequence Data, Neoplasm Proteins, Peptide Mapping, Phosphorylation, Precipitin Tests, Protein Kinase C, Tetradecanoylphorbol Acetate, Threonine, Time Factors, Transfection, Signal Transduction, CHO Cells, Apoptosis, Paclitaxel, Protein Structure, Tertiary, Proto-Oncogene Proteins c-bcl-2, Okadaic Acid, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, Cell Line, Tumor, Mice, Myeloid Cell Leukemia Sequence 1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.